Publications by authors named "Loic Chartier"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

7,322,363

Total Likes

210,829

Extended Reach

7,582,876

Social Features

107
V
Visualizing non infectious and infectious Anopheles gambiae blood feedings in naive and saliva-immunized mice.
Valerie Choumet, Tarik Attout, Loïc Chartier, Huot Khun, Jean Sautereau, Annie Robbe-Vincent, Paul Brey, Michel Huerre, Odile Bain

June 2013

Videos about Article: user user user

3 9 104 11 23

View All Article and Social Media Activity
I
IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma.
Surendra Dasari, Kerstin Wenzl, Geoffrey M Nelson, Emmanuel Contreras Guzman, Zhiquan Wang, Loic Chartier

Blood Cancer Discov· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials.
Valentin Letailleur, Isabelle Chaillol, Fanny Cherblanc, Hervé Ghesquières, Frédéric Peyrade, Loïc Chartier

Blood Cancer J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk stratification of diffuse large B-cell lymphoma patients using plasma NMR-based metabolomics at diagnostic.
Aurélie Montagne, Gildas Bertho, Thomas Papastergiou, Loïc Chartier, Romain Ricci

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma.
Vincent Camus, Thierry Molina, Fabienne Desmots, Paul Blanc-Durand, Salim Kanoun, Loïc Chartier

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis.
Pablo Mozas, Romain Ould Ammar, Loïc Chartier, Loretta Nastoupil, Emmanuel Bachy

Br J Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the Association Between a Continuous Variable and a Time-To-Event Outcome: Going Beyond the Cut-Off Approach.
Tesla Murairi Mirimo, Cédric Portugues, Laurent Remontet, Loic Chartier, Anne-Ségolene Cottereau

Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
Clémentine Sarkozy, Loïc Chartier, Vincent Ribrag, Remy Gressin, Christian H Geisler

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significance.
Camille Laurent, Preeti Trisal, Bruno Tesson, Sahil Seth, Alicia Beyou, Loïc Chartier

Blood· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precautions to Consider in the Analysis of Prognostic and Predictive Indices.
Loïc Chartier, Aurélien Belot, Isabelle Chaillol, Mad-Hélénie Elsensohn, Cédric Portugues

J Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration.
Fabian Frontzek, Loïc Renaud, Ulrich Dührsen, Viola Poeschel, Sophie Bernard, Loïc Chartier

Leukemia· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case presentation and management of Lyme disease patients: a 9-year retrospective analysis in France.
Emeline Perthame, Loïc Chartier, Jean-Claude George, Marie Varloud, Elisabeth Ferquel

Front Med (Lausanne)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.
Raphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, Charles Herbaux, Anne Banos

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis.
Catherine Thieblemont, Bettina Altmann, Fabian Frontzek, Loïc Renaud, Loic Chartier

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.
Camille Laurent, Maria Flores, Loïc Chartier, Sarah Huet, Christopher R Bolen

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term excess mortality and net survival among elderly diffuse large B-cell lymphoma patients after front-line R-CHOP treatment.
Aurélien Belot, Vincent Camus, Cédric Portugues, Jérome Paget, Loic Chartier

Br J Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells.
Jean Galtier, Laetitia Vercellino, Loic Chartier, Pierre Olivier, Claire Tabouret-Viaud

Haematologica· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma.
Catherine Thieblemont, Loic Chartier, Ulrich Dührsen, Umberto Vitolo, Sally F Barrington

Blood Adv· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT.
Anne-Ségolène Cottereau, Michel Meignan, Christophe Nioche, Jérôme Clerc, Loic Chartier

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA.
Steven Le Gouill, Hervé Ghesquières, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Loic Chartier

Blood· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort.
Hervé Ghesquières, Cédric Rossi, Fanny Cherblanc, Sandra Le Guyader-Peyrou, Fontanet Bijou, Loic Chartier

BMC Public Health· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High total metabolic tumor volume at baseline predicts survival independent of response to therapy.
Laetitia Vercellino, Anne-Segolene Cottereau, Olivier Casasnovas, Hervé Tilly, Pierre Feugier, Loic Chartier

Blood· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study.
Anne Ségolène Cottereau, Annibale Versari, Stefano Luminari, Jehan Dupuis, Loïc Chartier

Blood· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
Anne-Ségolène Cottereau, Annibale Versari, Annika Loft, Olivier Casasnovas, Monica Bellei, Loic Chartier

Blood· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to H.J.A. Adams et al and E. Laffon et al.
Michel Meignan, Anne Ségolène Cottereau, Annibale Versari, Loïc Chartier, Jehan Dupuis

J Clin Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drawing optical fibers from three-dimensional printers.
John Canning, Md Arafat Hossain, Chunyang Han, Loic Chartier, Kevin Cook

Opt Lett· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis